Abstract
In this study, we show that dimethylargininase, a zinc protein involved in the regulation of nitric oxide synthase, is specifically elevated in neurons displaying cytoskeletal abnormalities and oxidative stress in Alzheimer disease (AD) while none of this enzyme was found in neurons in age- matched control cases. Seen in the context of earlier studies showing widespread nitric oxide related damage in AD and the role of dimethylargininase to activate nitric oxide synthetase, through catalytic removal of its endogenous inhibitors, these findings indicate major alterations in nitric oxide regulation in AD. Further, that low levels of zinc specifically inhibit dimethylargininase may provide a link between the numerous studies showing specific abnormalities in zinc and oxidative stress. Finally, our results provide additional evidence that oxidative stress- and nitric oxide-mediated events play important roles in the pathogenesis of AD.
Original language | English (US) |
---|---|
Pages (from-to) | 898-902 |
Number of pages | 5 |
Journal | Free Radical Biology and Medicine |
Volume | 25 |
Issue number | 8 |
DOIs | |
State | Published - Nov 15 1998 |
Funding
This work was supported through grants from the National Institutes of Health (MAS, GP), the American Health Assistance Foundation (MAS, GP) and by financial support from the Swiss National Science Foundation Grant 31-49460.096 (MV).
Keywords
- Alzheimer disease
- Nitric oxide
- Oxidative stress
- Transition metals
- Zinc
ASJC Scopus subject areas
- Biochemistry
- Physiology (medical)